Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189
Dementia01:30

Dementia

113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
113

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Attitudes Towards Brain Health and Dementia Risk Reduction Among Minoritised Ethnic Communities in the United Kingdom: A Cross-Sectional Survey Analysis.

International journal of geriatric psychiatry·2026
Same author

Family Group Conferences as an alternative to Initial Child Protection Conferences for families on the Child Protection pathway: Synopsis.

Health and social care delivery research·2026
Same author

Programmes that Integrate Parenting Support and Financial Well-Being Support: A Systematic Scoping Review.

Journal of prevention (2022)·2026
Same author

Cost utility and cost-effectiveness of the APPLE-Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce: economic evaluation embedded within a randomised controlled trial.

Age and ageing·2026
Same author

Lifestyle interventions for dementia prevention in low- and middle-income countries: a systematic review.

BMJ global health·2026
Same author

Exploring staff and service user experiences of personality disorder services in open prisons: A qualitative study of Pathways Enhanced Resettlement Support.

PloS one·2026

Related Experiment Video

Updated: Jul 2, 2025

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

6.9K

How might secondary dementia prevention programs work in practice: a pre-implementation study of the APPLE-Tree

Rachel M Morse1, Iain Lang2,3, Penny Rapaport4

  • 1Centre for Psychiatry and Mental Health, Wolfson Institute of Population Health, Queen Mary University of London, London, UK. rachel.morse.20@ucl.ac.uk.

BMC Geriatrics
|February 26, 2024
PubMed
Summary

Personalized dementia prevention shows promise, but scaling up faces challenges. Increased funding and adaptable program designs are crucial for widespread implementation of lifestyle-based interventions.

Keywords:
DementiaImplementation scienceMild cognitive impairmentPreventionSubjective cognitive decline

More Related Videos

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.2K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

608

Related Experiment Videos

Last Updated: Jul 2, 2025

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

6.9K
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.2K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

608

Area of Science:

  • Gerontology
  • Public Health
  • Implementation Science

Background:

  • Dementia affects over 850,000 people in the UK, with numbers projected to rise.
  • Personalized dementia prevention, focusing on lifestyle changes, offers a potential strategy to mitigate this increase.
  • Current evidence on scaling up these interventions to a population level remains limited.

Purpose of the Study:

  • To explore stakeholder perspectives on readiness for implementing dementia prevention programs.
  • To identify barriers and facilitators for scaling up the APPLE-Tree program, a lifestyle-based dementia prevention intervention.

Main Methods:

  • Semi-structured interviews were conducted with 26 health and social care professionals.
  • Participants had experience with older adults with memory concerns but no prior involvement with the APPLE-Tree program.
  • The Consolidated Framework for Implementation Research guided the interview and thematic analysis.

Main Results:

  • Stakeholders expressed positive beliefs regarding the efficacy of dementia prevention in enhancing cognition and well-being.
  • Key challenges identified include funding limitations and organizational capacity constraints.
  • Necessary modifications for program delivery and guidance were highlighted for better organizational and patient compatibility.

Conclusions:

  • Scaling up personalized dementia prevention faces significant challenges, necessitating increased funding and integrated care systems.
  • Successful population-level implementation requires clearly defined core and adaptable program components to meet diverse needs.